Jeffrey C. Loh-Doyle

Jeffrey C. Loh-Doyle

Keck School of Medicine at the University of Southern California

Los Angeles, California

Jeffrey Loh-Doyle, MD, is an assistant professor of clinical urology at the Keck School of Medicine at the University of Southern California (USC). He is a specialist in complex surgical reconstruction of the male urinary tract, male urinary incontinence, erectile dysfunction, sexual health, urethral stricture disease, and Peyronie’s disease. He joined the USC Institute of Urology after completing his medical degree, urology residency, and a fellowship training in male genitourinary reconstructive and prosthetic surgery at the Keck School of Medicine at USC.

Dr. Loh-Doyle’s areas of clinical and research interest include erectile dysfunction, male urinary incontinence, Peyronie’s disease, reconstruction of the urinary tract, and urologic oncology. In addition to urology, he also has a keen interest in health policy and quality improvement and participated in a two-year health care administration scholars program run by the Los Angeles County Department of Health. He was awarded a grant to improve the perioperative patient experience and is an active participant in several committees aimed at improving the delivery of sophisticated healthcare to the underserved.

Talks by Jeffrey C. Loh-Doyle

Contemporary Management and Prevention of Artificial Urinary Sphincter Erosion

Jeffrey Loh-Doyle, MD, provides a detailed analysis of artificial urinary sphincter (AUS) erosion, focusing on its causes, risk factors, management, and prevention. In this 18-minute presentation, Dr. Loh-Doyle examines this complication of the gold standard treatment for moderate to severe male stress urinary incontinence.
Dr. Loh-Doyle stresses the importance of identifying and managing AUS erosion. Patients may present with symptoms such as worsening incontinence, perineal or scrotal swelling, or, in more subtle cases, no symptoms at all. Cystoscopy is necessary to confirm erosion, especially in cases of severe discomfort or urinary retention. He discusses treatment, which involves removing the AUS device, draining the bladder with a catheter, and, depending on the severity of the erosion, repairing the urethra.
Prevention is key, especially in high-risk patients. Loh-Doyle advocates for conservative management, including using lower-pressure balloons, delayed activation, and educating patients on deactivating the device to reduce compressive forces. He also shares that, while AUS is effective, repeated erosions increase the likelihood of poor outcomes.

Read More